💊 CorDx Drugs of Abuse (DOA) Tests: Reliable Solutions for Screening and Compliance CorDx’s extensive portfolio of Drugs of Abuse (DOA) tests is engineered to meet the stringent requirements of clinical, workplace, and forensic screening programs globally. We provide fast, reliable, and compliant diagnostic tools essential for monitoring substance misuse and maintaining public safety.
🔬 Diagnostic Technology: Accuracy and Comprehensive Panel Coverage
Our DOA tests utilize highly specific Lateral Flow Immunoassays (LFIA) to detect the presence of illicit and prescription drugs and their metabolites in Urine samples. This technology is foundational to our offering:
Broad Spectrum Detection: Our portfolio covers the most common substances of abuse, including Amphetamines (AMP), Marijuana (THC), Cocaine (COC), Methamphetamine (MET), Opiates (OPI), Benzodiazepines (BZO), and many others (e.g., PCP, BUP, KET, MTD, BAR).
Customizable Cut-offs: Each test is precisely calibrated to specific drug concentration cut-off levels (e.g., 50ng/ml for THC, 300ng/ml for COC), ensuring results align with internationally recognized clinical and forensic standards.
Flexible Formats: We offer maximum versatility for various screening environments:
Strip/Cassette: Ideal for single or multi-drug testing with minimal sample volume.
Multi-Panel & Cup Formats (e.g., Multi-Drug 5/6/10/12): These integrated devices allow for the simultaneous detection of multiple drugs in a single step, significantly enhancing efficiency for highvolume screening programs. The Cup format (RDC12-10, DC120-41, etc.) simplifies collection and testing into one device, reducing handling time and contamination risk.
🏭 CorDx’s Integrated Supply Chain: Reliability and Global Scale
Reliability is non-negotiable in DOA testing. CorDx’s vertically integrated manufacturing guarantees the consistent quality and global supply necessary for critical testing programs:
High-Volume Capacity: Our controlled manufacturing process allows us to scale production efficiently, ensuring a constant and dependable supply for large corporate or government screening initiatives worldwide.
Cost-Effective Solutions: By managing the entire supply chain, we deliver cost-competitive tests that make broad-based, frequent screening programs financially viable for organizations globally.
Uniform Quality: Strict adherence to Good Manufacturing Practices (GMP) and robust quality control throughout the production process ensures consistent performance and minimized batch-to-batch variation, which is essential for legal and clinical accountability.
✅ Regulatory Compliance: Trusted in Clinical and Legal Settings
Our tests are designed to meet the rigorous regulatory standards required for use in regulated environments, providing confidence in the results:
US Market Access: Many of our core DOA tests are covered by FDA 510(k) clearance, confirming their safety and effectiveness for use in the United States.
European Market Access: The majority of our portfolio, including tests for PCP and BUP, holds the CE Mark, ensuring conformity with the essential health and safety requirements of the European Union.
By combining superior diagnostic technology with scalable, qualitycontrolled manufacturing and robust global regulatory approval, CorDx stands as a trusted partner in global efforts to manage drug misuse through accurate and accessible screening.